No takes yet. Share an insight, caveat, or question.
Analysis reveals stakeholder participation remains robust in U.S. regulatory policymaking during transition periods, suggesting legitimacy.
Christopher Carrigan (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: